欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

全球心脏再同步治疗心脏起搏器市场报告(2016-2020年)

Global Cardiac Resynchronization Therapy Pacemaker Market 2016-2020

加工时间:2016-10-25 信息来源:EMIS 索取原文[48 页]
关键词:CRT-Ps;传统起搏器;先进可植入;监测信号;心室协调;心脏功能
摘 要:

CRT-Ps are an advanced implantable form of conventional pacemakers. They help the heart function efficiently by monitoring its signals and coordinating with the ventricles to contract at the same time. These devices resynchronize the heart's rhythm to improve breathlessness and fatigue, and avoid dizziness and fainting in individuals. Physicians surgically implant the CRT-P under the skin, below the collarbone. They connect the electrical leads through a blood vessel into the heart. Unlike conventional pacemakers, CRT-Ps have two leads: one placed into the right ventricle and the other in the right atrium. An extra lead is implanted on the left side of the heart to stimulate the left ventricle, assisting the heart to pump efficiently. The implantation process and the use of these devices can cause infections around the implant site and damage the blood vessels, heart wall, and other organs.


目 录:

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Cost analysis of CRT-Ps and implantation

PART 07: Geographical segmentation

CRT-P market in Americas

CRT-P market in EMEA

CRT-P market in APAC

PART 08: Key leading countries

US

France

UK

Germany

PART 09: Market drivers

Incidence of cardiovascular diseases

Government-aided awareness programs

Implementation of minimally invasive procedures

Demand for CRT-Ps in APAC

PART 10: Impact of drivers

PART 11: Market challenges

Presence of alternatives

Lack of skilled personnel

Risk of potential complications

Limitations of CRT-Ps in pediatric patients

PART 12: Impact of drivers and challenges

PART 13: Market trends

Focus on R&D and clinical trials

Popularity of robot-assisted cardiac surgery

Focus on leadless CRT-Ps

PART 14: Vendor landscape

Competitive scenario

PART 15: Key vendor analysis

BIOTRONIK

Boston Scientific

LivaNova

Medtronic

St. Jude Medical

PART 16: Appendix

List of abbreviations

PART 17: Explore Technavio


© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服